JMP Securities Maintains Market Outperform on Aura Biosciences, Raises Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has maintained a Market Outperform rating on Aura Biosciences and raised its price target from $19 to $23, indicating confidence in the company's future performance.
September 13, 2024 | 11:18 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has increased its price target for Aura Biosciences from $19 to $23, maintaining a Market Outperform rating. This suggests a positive outlook for the company's stock.
The increase in price target from $19 to $23 by JMP Securities, along with maintaining a Market Outperform rating, indicates a strong positive sentiment towards Aura Biosciences. This is likely to boost investor confidence and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100